Clinical Trial Update: Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase I/IIa trial exploring gemcitabine with trastuzumab and pertuzumab in previously treated metastatic HER2-positive breast cancer has completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-07-20